Literature DB >> 10969846

Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family history.

H Shimomura1, T Sanke, T Hanabusa, K Tsunoda, H Furuta, K Nanjo.   

Abstract

Islet-1 (Isl-1) is one of the transcription factors that play an important role for the formation of the islet cells. We scanned the Isl-1 gene in 77 Japanese type 2 diabetic patients with a family history and found a heterozygous nonsense mutation (Q310X) in 1 diabetic patient. The mutation was not found in 180 nondiabetic subjects. This mutation is located in the putative transactivation domain and deletes 40 amino acids of the COOH-terminal lesion. The Q310X mutant exhibited a 50% reduction in activity compared with the wild-type when tested for stimulation of transcription of a human amylin promoter-linked luciferase reporter gene in betaTC3 cells. The patient was a 49-year-old nonobese man who was diagnosed as having type 2 diabetes at 32 years of age and has been treated with sulfonylureas. The mutation was found in his mother, who has type 2 diabetes, and in his 14-year-old daughter, who has normal glucose tolerance but a relatively low insulin response. This is the first reported finding of Isl-1 gene mutation in type 2 diabetes. Although Isl-1 is not a common predisposing gene for Japanese type 2 diabetes, the mutation in this gene may be a rare cause of diabetes in isolated families.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10969846     DOI: 10.2337/diabetes.49.9.1597

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

Review 1.  The role of homeodomain transcription factors in heritable pituitary disease.

Authors:  Kelly L Prince; Emily C Walvoord; Simon J Rhodes
Journal:  Nat Rev Endocrinol       Date:  2011-07-26       Impact factor: 43.330

2.  Alx3-deficient mice exhibit decreased insulin in beta cells, altered glucose homeostasis and increased apoptosis in pancreatic islets.

Authors:  M Mirasierra; A Fernández-Pérez; N Díaz-Prieto; M Vallejo
Journal:  Diabetologia       Date:  2010-11-21       Impact factor: 10.122

Review 3.  Molecular targeting of pancreatic disorders.

Authors:  Kiichi Tamada; Xiao-Ping Wang; F Charles Brunicardi
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

Review 4.  LIM-homeodomain genes in mammalian development and human disease.

Authors:  Chad S Hunter; Simon J Rhodes
Journal:  Mol Biol Rep       Date:  2005-06       Impact factor: 2.316

Review 5.  BMP signaling and its modifiers in kidney development.

Authors:  Ryuichi Nishinakamura; Masaji Sakaguchi
Journal:  Pediatr Nephrol       Date:  2013-11-12       Impact factor: 3.714

6.  Missense mutations in the human insulin promoter factor-1 gene are not a common cause of type 2 diabetes mellitus in Taiwan.

Authors:  Ming-Yuh Shiau; Chien-Ning Huang; Jung-Hua Liao; Yih-Hsin Chang
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

7.  Impaired enteroendocrine development in intestinal-specific Islet1 mouse mutants causes impaired glucose homeostasis.

Authors:  Natalie A Terry; Erik R Walp; Randall A Lee; Klaus H Kaestner; Catherine Lee May
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-09-11       Impact factor: 4.052

8.  LIM-homeodomain transcription factor Isl-1 mediates the effect of leptin on insulin secretion in mice.

Authors:  Juan Chen; Rui Fu; Yan Cui; Yu-shan Li; Ji-rong Pan; Jia-li Liu; Hao-shu Luo; Jing-dong Yin; De-fa Li; Sheng Cui
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

9.  Islet1 deletion causes kidney agenesis and hydroureter resembling CAKUT.

Authors:  Yusuke Kaku; Tomoko Ohmori; Kuniko Kudo; Sayoko Fujimura; Kentaro Suzuki; Sylvia M Evans; Yasuhiko Kawakami; Ryuichi Nishinakamura
Journal:  J Am Soc Nephrol       Date:  2013-05-02       Impact factor: 10.121

Review 10.  Revealing transcription factors during human pancreatic β cell development.

Authors:  Elizabeth Conrad; Roland Stein; Chad S Hunter
Journal:  Trends Endocrinol Metab       Date:  2014-05-12       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.